Index
renal pelvis
retrograde catheterization, 411
squamous cell carcinoma
tumors of, 841-844
renal pelvis/renal pelvis tumors
adenocarcinoma, 843
adenosquamous carcinoma, 843
squamous cell carcinoma, 843
undifferentiated, 844
ureter tumors compared, 427
urothelial carcinoma, 842-843
papillary urothelial carcinoma,
grade II,
428
repair
cervix
electrocautery of, 966
glandular cell lesions, 233
reactive and regenerative changes,
146-147
inflam m ation, 95
microscopic evaluation, 66
mismatch repair genes (MMR), 13
RER (rough endoplasmic reticulum),
7
reserve cell hyperplasia
cervix, 139, 140-141, 172
respiratory tract, 312
reserve cells
and endocervix, 135
respiratory tract, 312
respiratory infections
adenovirus, 321
bacterial, 321
cytology, 318-329
cytomegalovirus infection, 320
fungal, 321-327
organisms, forms,
319
,
320
parasitic, 327-329
viral, 319-321
respiratory tract
see also bronchial entries
and Lungs
anatomy and histology, 306,
307
,
308
bronchial aspirates, and washings, 305
bronchial brushings, 305
bronchial cells, 308-310
bronchial epithelium
see
bronchial
epithelium
bronchial washings, 305
bronchioalveolar carcinoma (BAC)
see
BAC
(bronchioalveolar carcinoma)
bronchoalveolar lavage, 305
bronchopulmonary dysplasia, 315
bronchosopy, 305
cellular components, 315-317
noncellular inaminate components,
317-318
cytology
abnormal epithelial cells, 308-315
normal epithelial cells, 308
cytopreparatory techniques, 997-998
epithelial cells
abnormal, 308-315
changes in, 315
normal, 308
fine needle aspiration biopsy, 305-306
image-guided, 604-605
hyperplasia, 309-310
hyperplasia, bronchial epithelium,
311
lower, effects o f radiation on, 955-956
pediatric disorders, 920-923
respiratory tract
(Continued)
reactive alveolar epithelium,
311, 312
reserve cells, 312
sampling and cytopreparatory techniques,
304-306
sputum
see
sputum
squamous cells, 308-310
squamous metaplasia, 310, 312-314
retinal pigment epithelial cells (RPE), eye, 463
retinoblastomas, eye, 464, 466
RET/PTC
gene arrangement, papillary thyroid
carcinoma, 38-39
retroperitoneum
anatomy, 859
benign tumors and masses, 859
diagnostic accuracy o f FNA, 864-865
embryonal rhabdomyosarcomas,
860-861
germ cell tumors, 863-864
imaging techniques, 857
intra-abdominal desmoplastic small-cell
tumor, 861
leiomyosarcoma, 860
liposarcoma, 859-860
lymphoma, 862
malignant fibrous histiocytoma, 860
metastatic tumors, 862
neoplastic lesions, 859
pediatric disorders, 946
round cell sarcoma, 860
sarcomas, 859
reverse transcriptase (RT)-PCR techniques,
42, 1085
rhabdoid tumors, 570,
571
extrarenal, 491
rhabdomyoma
in children, 939
head and neck, 628
skeletal muscle tumors, 480
rhabdomyosarcoma (RMS)
see
RMS
(rhabdomyosarcoma)
rhabdosarcoma
embryonal, vagina, 282-283
lower urinary tract, 426
orbit, 462
rheumatoid disease
cytology, 536-537
histopathology, 536
lympadenopathy, 678
necrotic background material, 537-538
pleural effusions,
538
pleuritis, 537,
538
ragocyte cell, 538
rheumatoid arthritis, 538
rheumatoid nodules, skin, 503
ribonucleic acid (RNA), 4
ribosomes (protein production machinery)
and DNA, 4
endoplasmic reticulum, 7
Richard Allan blueing reagent, 982
Riedel's disease o f thyroid gland, 638-639
RMC (renal medullary carcinoma), 836-837
RMS (rhabdomyosarcoma)
in children, 933, 939, 943
embryonal, retroperitoneum,
860-861
skeletal muscle tumors, 480
RNA (ribonucleic acid), 4
probes, 112
Romanowsky staining
adenocarcinoma, effusions, 552
basophils, 532
breast disorders, 719
gastrointestinal tract, 374
granuloma inguinale, 99
herpes simplex virus infection, 108
Hodgkin's disease, 568
kidneys, 813
leukemias, 566
lymphomas, 566, 676
mast cells, 532
Papanicolaou compared,
589
parasitic infections, 123
red blood cells, 529
thin-needle aspiration method, 582, 588
RPE (retinal pigment epithelial) cells, eye, 463
RR (rapid rescreening), quality assurance
measures, 61
RTK (receptor tyrosine kinase) gene, papillary
thyroid carcinoma, 38
S
S100 (immunhistochemical stain), 100
safety precautions, quality assurance
measures, 60
Sakura Tissue-Tek DRS Automatic Slide
Stainer, 988
salivary duct carcinoma, salivary glands,
621-622
salivary glands, 607-624
acinar cells, 608
acinic cell carcinoma, 619-621,
620
adenocarcinoma not otherwise specified,
622,
623
adenoid cystic carcinoma, 617-618
adenolymphoma, 614-615
anatomy and histology, 607-608
aspiration technique, 607
basal cell adenoma, 616
benign lympoepithelial lesions, 610-611
benign tumors, 611-616
carcinoma ex pleomorphic adenoma, 621
clear cell adenoma, 616
cysts, 608-609
cytology, 608
diagnostic accuracy, 623-624
fine needle aspiration biopsy,
image-guided, 604
inflam m atory disease, 609-610
lymphocyte dominate benign lesions,
610-611
malignant mixed tumor, 622
malignant tumors, 617-623
mesenchymal tumors, 622
metastatic disease, 622
minor, 608
mucoepidermoid carcinoma, 618-619
myoepithelial carcinoma, 621
myoepithelioma, 613-614
neoplasms, 611-623
nodular oncocytic hyperplasia, 609-610
non-neoplastic lesions, 608-610
oncocytoma (oxyphillic adenomas),
615-616
papillary cystadenolymphoma, 614-615
pleomorphic adenoma (mixed tumor),
611,
612
,
613
1115
previous page 1098 ComprehensiveCytopathology 1104p 2008 read online next page 1100 ComprehensiveCytopathology 1104p 2008 read online Home Toggle text on/off